Michael Davis, M.D.

Michael K Davis, Jr, M.D.

(352) 627-9315

Request an Appointment


  • Broge T, Nguyen N, Sacks A, Davis MK. Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy. Inflamm Bowel Dis, 2013 Apr;19(5):E75-7.
  • Davis MK, Andres JM, Jolley CD, et al. Anti-OmpC in the Absence of ASCA and ANCA is an Unreliable Marker of Crohn's Disease and Ulcerative Colitis. J Pediatr Gastroenterol Nutr, 2007 Oct, 45:409 and ndash;413.
  • Davis MK, Valentine JF, Weinstein DA, Polyak S. Antibodies to CBir1 are associated with glycogen storage disease type Ib. J Pediatr Gastroenterol Nutr. 2010 Jul;51(1):14-8.
  • Arnon R, Kerkar N, Davis MK, Anand R, Yin W, Gonz and aacute;lez-Peralta RP; SPLIT Research Group. Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience. Pediatr Transplant. 2010 Sep 1;14(6):796-805. Epub 2010 Jun 27.
  • Davis MK, Weinstein DA. Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure. Pediatr Transplant. 2008 Mar;12(2):137-45.
  • Davis MK, Andres JM. Cholestasis in Neonates and Infants. In: Neu J, ed. Neonatology:Questions and Controversies:Gastroenterology. Saunders, an imprint of Elsevier. Philadelphia, PA 2008.
  • Sacks A, Davis MK. A curious case of red-brown urine in a child taking mesalamine. J Pediatr Gastroenterol Nutr. 2013 May;56(5):e38-9.
  • Davis MK, Rufo PA, Polyak SF, Weinstein DA. Adalimumab for the treatment of Crohn-like colitis and enteritis in glycogen storage disease type Ib. J Inherit Metab Dis. 2008 Jan 5

Research Interests

  • Continuous improvement
  • Process management
  • Electronic medical record
  • Best practices
  • Reliable methods